213598-15-3 Usage
Description
3-Chloro-4-ethoxybenzoic acid 97, with the molecular formula C9H9ClO3, is a white to off-white crystalline solid that is soluble in organic solvents. This chemical compound is known for its high purity and is commonly used as an intermediate in the synthesis of various products, including pharmaceuticals, agrochemicals, dyes, pigments, and other specialty chemicals.
Uses
Used in Pharmaceutical Industry:
3-Chloro-4-ethoxybenzoic acid 97 is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs and improve the efficacy of existing ones.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloro-4-ethoxybenzoic acid 97 serves as an intermediate in the production of various agrochemicals, helping to enhance crop protection and yield.
Used in Dye and Pigment Manufacturing:
3-Chloro-4-ethoxybenzoic acid 97 is utilized in the manufacturing of dyes and pigments, contributing to the creation of a wide range of colors and shades for various applications.
Used in Specialty Chemicals Production:
This chemical compound is also employed in the production of specialty chemicals, where its unique properties allow for the development of innovative and high-quality products for diverse industries.
Check Digit Verification of cas no
The CAS Registry Mumber 213598-15-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,3,5,9 and 8 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 213598-15:
(8*2)+(7*1)+(6*3)+(5*5)+(4*9)+(3*8)+(2*1)+(1*5)=133
133 % 10 = 3
So 213598-15-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H9ClO3/c1-2-13-8-4-3-6(9(11)12)5-7(8)10/h3-5H,2H2,1H3,(H,11,12)
213598-15-3Relevant articles and documents
S1P RECEPTORS MODULATORS
-
Page/Page column 116, (2010/04/30)
The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.
Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
-
, (2008/06/13)
Compounds of formula (I) and pharmaceutically acceptable salts and solvates: where R1is hydrogen, C1-6alkyl (optionally substituted by hydroxy or C1-4alkoxy), phenyl-C1-4alkyl-, C1-6alkenyl, C1-6
